Literature DB >> 15281345

Advances in pituitary pathology: use of novel techniques.

Ricardo V Lloyd1.   

Abstract

Many new techniques are rapidly being developed and applied to the study of normal and neoplastic pituitary tissues. These range from techniques used for the past few decades such as in situ hybridization to more recent developments such as comparative genomic hybridization, laser capture microdissection, DNA and tissue arrays, proteomics, and RNA interference technology. These approaches have been applied to answer many challenging questions about pituitary function and pathophysiology. This chapter reviews many of these recent developments and shows their applications to pituitary biology in order to demonstrate how these new techniques are providing insights about basic aspects, clinical, and pharmacologic knowledge of the pituitary gland and of pituitary tumors.

Entities:  

Mesh:

Year:  2004        PMID: 15281345     DOI: 10.1159/000079043

Source DB:  PubMed          Journal:  Front Horm Res        ISSN: 0301-3073            Impact factor:   2.606


  3 in total

Review 1.  DNA microarrays: recent developments and applications to the study of pituitary tissues.

Authors:  Xiang Qian; Bernd W Scheithauer; Kalman Kovacs; Ricardo V Lloyd
Journal:  Endocrine       Date:  2005-10       Impact factor: 3.633

2.  Proteomic analysis of prolactinoma cells by immuno-laser capture microdissection combined with online two-dimensional nano-scale liquid chromatography/mass spectrometry.

Authors:  Yingchao Liu; Jinsong Wu; Guoquan Yan; Ruiping Hou; Dongxiao Zhuang; Luping Chen; Qi Pang; Jianhong Zhu
Journal:  Proteome Sci       Date:  2010-01-29       Impact factor: 2.480

3.  Clinical, Biological, Radiological Pathological and Immediate Post-Operative Remission of Sparsely and Densely Granulated Corticotroph Pituitary Tumors: A Retrospective Study of a Cohort of 277 Patients With Cushing's Disease.

Authors:  Beata Rak; Maria Maksymowicz; Monika Pękul; Grzegorz Zieliński
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-31       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.